Exploration of Key Immune-Related Transcriptomes Associated with Doxorubicin-Induced Cardiotoxicity in Patients with Breast Cancer

Cancer statistics, 2022

(2022) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Identification of key tumor stroma-associated transcriptional signatures correlated with survival prognosis and tumor progression in breast cancer

(2022) Md. Nazim Uddin et al.   Breast Cancer

Risk of heart disease following treatment for breast cancer – results from a population-based cohort study

(2022) Haomin Yang et al.   eLife

Doxorubicin induced immune abnormalities and inflammatory responses via HMGB1, HIF1-α and VEGF pathway in progressive of cardiovascular damage

(2022) Ahmad Syukri et al.   Annals of Medicine and Surgery

Cryo-EM structures of two human B cell receptor isotypes

(2022) Xinyu Ma et al.   SCIENCE

Identification of key genes with prognostic value in gastric cancer by bioinformatics analysis

(2022) Rongsheng Wang et al.   Frontiers in Genetics

Comprehensive analysis and validation of novel immune and vascular remodeling related genes signature associated with drug interactions in pulmonary arterial hypertension

(2022) Jie Wang et al.   Frontiers in Genetics

The Innate Immune System in Cardiovascular Diseases and Its Role in Doxorubicin-Induced Cardiotoxicity

(2022) Anchit Bhagat et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Identification of immune cell function in breast cancer by integrating multiple single-cell data

(2022) Liyuan Zhang et al.   Frontiers in Immunology

Molecular mechanisms of doxorubicin-induced cardiotoxicity: novel roles of sirtuin 1-mediated signaling pathways

(2021) Jie Wang(a) et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Effect of doxorubicin on cardiac lipid metabolism-related transcriptome and the protective activity of Alda-1

(2021) Leonardo da Cunha Menezes Souza et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Regulated cell death pathways in doxorubicin-induced cardiotoxicity

(2021) Effimia Christidi et al.   Cell Death & Disease

Roles of BTLA in Immunity and Immune Disorders

(2021) Zhaochen Ning et al.   Frontiers in Immunology

Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management

(2021) Pushkar Singh Rawat et al.   BIOMEDICINE & PHARMACOTHERAPY

SPIB acts as a tumor suppressor by activating the NFkB and JNK signaling pathways through MAP4K1 in colorectal cancer cells

(2021) Xunping Zhao et al.   CELLULAR SIGNALLING

Identification of Underlying Hub Genes Associated with Hypertrophic Cardiomyopathy by Integrated Bioinformatics Analysis

(2021) Zetao Ma et al.   Pharmacogenomics & Personalized Medicine

Identification of Key Pathways and Genes in SARS-CoV-2 Infecting Human Intestines by Bioinformatics Analysis

(2021) Ji-Chun Chen et al.   BIOCHEMICAL GENETICS

Prioritization of causal genes for coronary artery disease based on cumulative evidence from experimental and in silico studies

(2020) Alexandra S. Shadrina et al.   Scientific Reports

Binding mechanisms of therapeutic antibodies to human CD20

(2020) Anand Kumar et al.   SCIENCE

Predicting Diagnostic Gene Biomarkers Associated With Immune Infiltration in Patients With Acute Myocardial Infarction

(2020) Enfa Zhao et al.   Frontiers in Cardiovascular Medicine

Immune profiling of pre- and post-treatment breast cancer tissues from the SWOG S0800 neoadjuvant trial

(2019) Xiaotong Li et al.   Journal for ImmunoTherapy of Cancer

Identification of Transcriptional Markers and microRNA–mRNA Regulatory Networks in Colon Cancer by Integrative Analysis of mRNA and microRNA Expression Profiles in Colon Tumor Stroma

(2019) Md. Nazim Uddin et al.   Cells

Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association

(2018) Laxmi S. Mehta et al.   CIRCULATION

Crystal structure of B-cell co-receptor CD19 in complex with antibody B43 reveals an unexpected fold

(2018) Alexey Teplyakov et al.   PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS

Adjuvant Anthracyclines in Breast Cancer: What Is Their Role?

(2018) Ami N. Shah et al.   ONCOLOGIST

STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets

(2018) Damian Szklarczyk et al.   NUCLEIC ACIDS RESEARCH

Breast Cancer and Heart Failure

(2018) Zakaria Almuwaqqat et al.   Heart Failure Clinics

Doxorubicin-induced heart failure in cancer patients: A cohort study based on the Korean National Health Insurance Database

(2018) Young Ae Kim et al.   Cancer Medicine

Immune mechanisms in heart failure

(2017) Yingying Zhang et al.   EUROPEAN JOURNAL OF HEART FAILURE

Immune response proteins as predictive biomarkers of doxorubicin-induced cardiotoxicity in breast cancer patients

(2017) Li-Rong Yu et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Autophagic dysregulation in doxorubicin cardiomyopathy

(2017) Jordan J. Bartlett et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Crystal Structure of the Extracellular Domain of the Human Dendritic Cell Surface Marker CD83

(2017) Christiane S. Heilingloh et al.   JOURNAL OF MOLECULAR BIOLOGY

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses

(2017) Zefang Tang et al.   NUCLEIC ACIDS RESEARCH

Polymorphic Variations Associated With Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients

(2017) Valentina K. Todorova et al.   ONCOLOGY RESEARCH

G9a drives hypoxia-mediated gene repression for breast cancer cell survival and tumorigenesis

(2017) Francesco Casciello et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes

(2017) Liqun Zhao et al.   Scientific Reports

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

(2016) Jose Luis Zamorano et al.   EUROPEAN HEART JOURNAL

Human induced pluripotent stem cell–derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity

(2016) Paul W Burridge et al.   NATURE MEDICINE

Unknown

(2015) Enkui Hao et al.   MOLECULAR MEDICINE

limma powers differential expression analyses for RNA-sequencing and microarray studies

(2015) Matthew E. Ritchie et al.   NUCLEIC ACIDS RESEARCH

Interaction of doxorubicin with a regulatory element of hmga1 and its in vitro anti-cancer activity associated with decreased HMGA1 expression

(2014) Md. Zahid Akhter et al.   JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY

Pathview: an R/Bioconductor package for pathway-based data integration and visualization

(2013) Weijun Luo et al.   BIOINFORMATICS

Genomic Profiling Reveals the Potential Role of TCL1A and MDR1 Deficiency in Chemotherapy-Induced Cardiotoxicity

(2013) Timothy A. McCaffrey et al.   International Journal of Biological Sciences

tRNA Binding, Structure, and Localization of the Human Interferon-Induced Protein IFIT5

(2013) George E. Katibah et al.   MOLECULAR CELL

InnateDB: systems biology of innate immunity and beyond—recent updates and continuing curation

(2012) Karin Breuer et al.   NUCLEIC ACIDS RESEARCH

pROC: an open-source package for R and S+ to analyze and compare ROC curves

(2011) Xavier Robin et al.   BMC BIOINFORMATICS

Structures of BIR domains from human NAIP and cIAP2

(2009) Maria Dolores Herman et al.   Acta Crystallographica Section F-Structural Biology and Crystallization Communications